For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Amdocs Limited (DOX) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-27): Designation Watch · Gem Score +32 (−100…+100 Quality+Value blend) · Quality 39 · Value 27 · Sentiment 1 (timing only, not weighted) · Composite fair value $91.27 vs $61.35 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Amdocs Limited
DOX NASDAQAmdocs Limited is a leading provider of software and services to communications and media companies worldwide. The company specializes in innovative solutions for digital network transformation, including Generative AI to enhance productivity, 5G network capabilities, automation for complex operations, cloud migration for agility, and digital customer experiences. Its offerings support end-to-end B2B processes from sales to monetization, alongside solutions for financial services to leverage new technologies. Amdocs Limited partners with major operators like Bell, BT, T-Mobile, and Vodafone to deliver intelligent operations, business continuity, and strategic modernization. Headquartered in St. Louis, Missouri, with key operations including development centers in India and Israel, the company focuses on IT services and consulting within the technology sector, enabling clients in developed and emerging markets to meet evolving customer, IT, and network demands.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
Amdocs Limited is a foreign private issuer — it reports to the U.S. SEC once a year (on Form 20-F or 40-F) rather than filing the quarterly statements (10-Q) that U.S.-domiciled companies must submit. Our financial statements are read directly from SEC filings, so for this company only annual figures exist at the source.
This is a property of how the company files, not missing or broken data — its filing history shows 17 annual reports, the latest filed 2024-12-17, and no quarterly filings . The company may still publish quarterly results on its own investor-relations site.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.25
Total Equity: $3.50B
Shares: 116,046,353
Total Debt: $646.29M
Cash: $346.09M
EBITDA: $819.46M
Total Debt: $646.29M
Cash: $346.09M
Revenue: $5.00B
Revenue: $5.00B
Revenue: $5.00B
Total Equity: $3.50B
Tax Rate: 16.0%
Equity: $3.50B
Total Debt: $646.29M
Cash: $346.09M
Current Liabilities: $1.47B
Long-Term Debt: $646.29M
Total Debt: $646.29M
Total Equity: $3.50B
Shares: 116,046,353
Shares: 116,046,353
CapEx: -$105.50M
Shares: 116,046,353
Stock Price: $55.36
Net Income: $493.20M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 3, 2026 4:50pm (65d ago)| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $4.2B | $4.3B | $4.6B | $4.9B | $5.0B |
| Cost of Revenue | $2.8B | $2.8B | $3.0B | $3.2B | $3.2B |
| Gross Profit | $1.4B | $1.5B | $1.6B | $1.7B | $1.8B |
| Operating Expenses | $818.7M | $879.0M | $954.4M | $1.1B | $1.1B |
| Operating Income | $594.8M | $598.7M | $664.8M | $654.0M | $628.6M |
| Net Income | $497.8M | $688.4M | $549.5M | $540.7M | $493.2M |
| EBITDA | $790.5M | $802.5M | $863.3M | $839.2M | $819.5M |
| EPS | $3.73 | $5.36 | $4.47 | $4.52 | $4.27 |
| EPS (Diluted) | $3.71 | $5.32 | $4.44 | $4.49 | $4.25 |
Balance Sheet (Annual)
Last updated: Aug 3, 2026 4:50pm (65d ago)| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | $983.2M | $709.1M | $573.4M | $520.1M | $346.1M |
| Total Current Assets | $2.1B | $2.1B | $2.0B | $1.9B | $1.8B |
| Total Assets | $6.3B | $6.5B | $6.4B | $6.4B | $6.4B |
| Current Liabilities | $1.2B | $1.3B | $1.3B | $1.4B | $1.5B |
| Long-Term Debt | $644.0M | $644.6M | $645.1M | $645.7M | $646.3M |
| Total Liabilities | $2.7B | $2.9B | $2.8B | $2.9B | $2.9B |
| Total Equity | $3.7B | $3.6B | $3.6B | $3.6B | $3.5B |
| Retained Earnings | $5.3B | $5.9B | $6.2B | $6.5B | $6.8B |
Cash Flow (Annual)
Last updated: Aug 3, 2026 4:50pm (65d ago)| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | $658.1M | $925.8M | $756.7M | $822.6M | $724.4M |
| Capital Expenditure | — | -$210.4M | -$227.2M | -$124.4M | -$105.5M |
| Free Cash Flow | — | $715.4M | $529.5M | $698.3M | $618.9M |
| Acquisitions (net) | -$249.4M | -$142.7M | -$24.4M | -$121.8M | -$86.8M |
| Net Debt Issued / (Repaid) | $643.9M | $0 | $0 | — | — |
| Dividends Paid | -$164.1M | -$177.5M | -$186.1M | -$199.5M | -$212.0M |
| Stock Buybacks | -$360.9M | -$680.0M | -$508.5M | -$489.5M | -$563.1M |
| Net Change in Cash | $511.6M | -$274.1M | -$135.7M | -$53.3M | -$174.0M |
Growth Trends (YoY %)
Last updated: Aug 3, 2026 4:50pm (65d ago)| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue Growth | +2.9% | +6.7% | +6.8% | +2.4% |
| Gross Profit Growth | +4.5% | +9.6% | +6.7% | +1.6% |
| Operating Income Growth | +0.7% | +11.0% | -1.6% | -3.9% |
| Net Income Growth | +38.3% | -20.2% | -1.6% | -8.8% |
| EBITDA Growth | +1.5% | +7.6% | -2.8% | -2.3% |
Dividend History (Last 20)
Last updated: Aug 3, 2026 4:52pm (65d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-30 | $0.57 | — | — | — |
| 2026-03-31 | $0.57 | — | — | — |
| 2025-12-31 | $0.53 | — | — | — |
| 2025-09-30 | $0.53 | — | — | — |
| 2025-06-30 | $0.53 | — | — | — |
| 2025-03-31 | $0.53 | — | — | — |
| 2024-12-31 | $0.48 | — | — | — |
| 2024-09-30 | $0.48 | — | — | — |
| 2024-06-28 | $0.48 | — | — | — |
| 2024-03-27 | $0.48 | — | — | — |
| 2023-12-28 | $0.44 | — | — | — |
| 2023-09-28 | $0.44 | — | — | — |
| 2023-06-29 | $0.44 | — | — | — |
| 2023-03-30 | $0.44 | — | — | — |
| 2022-12-29 | $0.40 | — | — | — |
| 2022-09-29 | $0.40 | — | — | — |
| 2022-06-29 | $0.40 | — | — | — |
| 2022-03-30 | $0.40 | — | — | — |
| 2021-12-30 | $0.36 | — | — | — |
| 2021-09-29 | $0.36 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Not computed yetNarrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-22 14:20The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Starting with the raw numbers before touching the model chorus: revenue has crawled from $4.17B (FY20) to $5.00B (FY24) — a 4.6% CAGR that's decelerating (FY24 YoY was just 2.3%). More concerning, operating income peaked at $664.8M in FY22 and has since declined to $628.6M despite $420M of incremental revenue, meaning incremental operating margin was actually negative over the last two years. Gross margin sits at 35.1% — respectable but not software-like; this is a services business with services economics. Net income at $493.2M is down from $549.5M in FY22 and $688.4M in FY21 (though that year had a tax benefit). ROE of 14.1% and ROIC of 13.9% are fine but unremarkable, and both are trending down. FCF at $619M is the one genuinely bright number — 12.4% FCF margin, low capex intensity, and $724M operating cash flow provides real support at a $6.47B market cap (~10.5x FCF).
On the balance sheet: $646M debt against $346M cash and $3.5B equity — clean, low-lever, no distress. Insider data is nearly useless — two entries, one an award, one a token sale, dated 2026 (data anomaly worth flagging). The synthesis composite of $88-92 fair value implying +44% upside strikes me as aggressive given the earnings trajectory. That number appears to lean on multiple-expansion assumptions (rerating to software peers at 20-30x) that the fundamentals do not currently earn. If earnings are compounding at -5.3% and revenue at ~2-3%, the "no-growth floor" argument only works if you assume margins stabilize — but FY22→FY24 shows the opposite.
Where I part ways with the models: the Valuation Synthesis is too bullish and the Market Forces "value trap" call is too bearish. The truth is more mundane. This is a 14.4x P/E, 3.6% dividend yield, ~10x FCF business with a durable but unexciting customer base (tier-1 telcos), converting to more recurring revenue but at the cost of margin. That's not a $91 stock and it's not a $40 stock — it's roughly a $65-75 stock depending on whether operating margin stabilizes at 12.5% or drifts to 11%. The Thesis Evaluation score of -8 (essentially neutral) is closer to right than the synthesis's +44% upside. The narrative model correctly identifies this as "anchored/steady-compounder with minimal cult" — meaning fundamentals should dominate, and fundamentals say fairly-valued-to-modestly-undervalued, not deeply mispriced.
The contrarian case against even a mild bull view: telecom capex is genuinely under pressure globally, and Amdocs' top-5 customer concentration (AT&T, T-Mobile, etc.) means one large customer renegotiation could reset the earnings base by 5-10%. The declining operating income despite revenue growth is exactly the fingerprint of a vendor losing pricing power — customers are extracting concessions in exchange for renewals. Meanwhile, the "AI beneficiary" story is unfalsifiable on this timeline; if AI genuinely helped, we'd see it in gross margin, and gross margin has been flat at 35% for four years. Where I flag data thinness: no quarterly data provided (a serious gap for a mature earner where trajectory matters most), insider transactions dated 2026 suggest stale/corrupted feed, and the "Macro Headwinds" and "Lagging Sector Peers" signals are directional but unquantified.
Net verdict: I dissent partially from the synthesis. The stock is modestly undervalued — the 3.6% dividend, 10x FCF, and clean balance sheet provide meaningful downside protection, and a rerating to 16-17x earnings (still a discount to software peers) gets you to ~$70-75. But the +44% upside case requires margin recovery that the last 8 quarters of data explicitly contradicts. This is a hold-your-nose starter position for income-oriented investors, not a fat-pitch mispricing. The synthesis models are anchoring on multiples comparables while ignoring that the earnings denominator is actively shrinking.
GPT Reading
Amdocs looks like a durable but low-growth cash compounder that the market is valuing mostly correctly, with only a modest case for upside. The raw numbers are steady rather than exciting: revenue has climbed from $4.17B in 2020 to $5.00B in 2024, a 4.6% CAGR, while free cash flow reached $618.9M in 2024 on $724.4M of operating cash flow. At a $6.47B market cap, that is roughly a 9.6% FCF yield, which is attractive in isolation. The balance sheet is also fine: $646.3M of debt against $346.1M of cash and $3.50B of equity is not a strain. Return metrics are respectable for a mature software-services hybrid, with ROIC at 13.9% and ROE at 14.1%. If this were simply a stable annuity with flat earnings, 14.4x earnings and 9.0x EV/EBITDA would be undemanding.
But the more important story in the data is that earnings quality is solid while earnings power is not expanding. Revenue rose 2.4% in the latest year, yet operating income fell from $654.0M to $628.6M and net income dropped from $540.7M to $493.2M. Operating margin has slipped to 12.6% and net margin to 9.9%, down from 13.4% and 11.1% respectively in 2023; compared with 2022, the erosion is more visible. That means Amdocs is not just being marked down because investors are bored with telecom exposure; it is being discounted because incremental revenue is arriving at lower profitability. Gross margin has held around 35%, so the pressure appears below gross profit, which suggests mix, labor intensity, and execution costs are offsetting scale. That makes the “cheap software” framing too generous. This is not a high-margin platform waiting to be rediscovered; it is a services-heavy incumbent vendor with sticky customers but limited operating leverage.
That is why I do not buy the more aggressive undervaluation case pointing to a fair value in the high $80s or $90s. A company with revenue up 20% over four years but net income down from $497.8M in 2020 to $493.2M in 2024 is not demonstrating compounding earnings power, and the 2021 profit spike to $688.4M now looks more like a high-water mark than a base. Even so, the stock is not expensive. At the current price around $61, investors are getting a business that converts earnings to cash, pays a 3.6% dividend with a manageable 43% payout ratio, and carries modest leverage. My read is that the market is correctly treating Amdocs as a mature earner rather than mispricing it as distressed. Fair value is probably somewhat above the current quote because the cash generation is real, but not dramatically above it unless margins stabilize. I land in the high $60s to low $70s, not the high $80s.
The best argument against my caution is straightforward: the stock is cheap on almost every conventional metric for a business with this level of resilience. A 9.6% FCF yield, 14.4x P/E, 1.42x sales, and 9.0x EV/EBITDA for a company that has grown revenue every year for five years, maintained double-digit operating margins, and earns near-14% returns on capital is the kind of setup that often works if the business merely stops disappointing. A smart bull would also point out that free cash flow has compounded at 8.1%, faster than revenue, and that 2024 FCF of $618.9M actually exceeds reported net income by $125.7M, which argues the business is healthier than the EPS trend implies. If margins simply bottom here, a rerating to 16-17x earnings plus dividends could produce a respectable return. I weigh that less heavily because the same data also show that the company has not translated its larger revenue base into larger profits for four years, which is exactly what deserves a structural discount.
What changes my mind is simple. If Amdocs can post a year of at least 4-5% revenue growth while lifting operating margin back above 13% and net income back through $540M, I would become materially more bullish because it would show the recent compression was cyclical rather than structural. Conversely, if revenue growth falls to 1% or below while operating income drops under $600M and FCF slips meaningfully below $550M, then the current multiple is not cheap enough because the “stable cash cow” premise starts to crack. Until then, this is a solid but uninspiring compounder: good business, fair stock, not a hidden bargain.
Grok Reading
Amdocs prints the classic profile of a cash-rich mature services franchise that the market has written off as structurally impaired. Revenue has ground higher from $4.17B in 2020 to $5.00B in 2024 (4.6% CAGR), with the latest year still up 2.4%, yet operating income has rolled over from a $665M peak in 2022 to $629M and net income has slipped from $541M to $493M (−8.8% YoY). That divergence is the entire story: top-line resilience paired with margin compression, operating margin now 12.6% and net margin 9.9%. Against that, free cash flow of $619M on only $106M of capex is pristine—FCF exceeds reported earnings by 25% and equates to a roughly 9.6% yield at a $6.47B market cap. The balance sheet is unlevered (net debt ~$300M, D/E 0.18), the 3.6% dividend sits on a 43% payout, and the multiple stack—14.4× earnings, 9.0× EV/EBITDA, 1.42× sales—prices the firm as if low-single-digit growth and further margin bleed are permanent. At these levels growth is effectively free; the no-growth floor already sits well above $61.
The numbers do not support a collapse narrative. Gross margin has held near 35% across five years, ROIC is still 14%, and operating cash conversion remains high. This is a sticky B2B platform embedded in carrier BSS/OSS stacks, not a project shop about to vanish. The earnings CAGR of −5.3% is real and must be respected, but it coexists with an 8.1% FCF CAGR—evidence that the P&L is absorbing mix shift and investment while cash generation improves. At 14× earnings and sub-10× EV/EBITDA for a business still growing revenue and throwing off $600M-plus of FCF, the market is embedding a terminal decline that the trajectory does not yet justify.
The strongest opposing case is straightforward and quantitative: operating profit has now declined for two consecutive years while revenue rose, which is the classic signature of pricing power erosion and competitive displacement. Telco consolidation concentrates buyer leverage; project-heavy revenue creates renewal cliffs into 2025–26; and AI/automation could hollow out the consulting layer that pads margins. A smart bear will also note that 2021 net income of $688M makes today’s $493M look like a multi-year peak-to-trough drawdown, and that sector peers have re-rated while DOX has not—consistent with a value trap rather than a mispricing. I weigh this less heavily because FCF has not followed earnings down, leverage is negligible, and the absolute valuation already discounts a severe outcome. Margin compression is a risk to monitor, not yet proof of franchise destruction.
I would flip if FY2025 operating margin falls another 100–150 bp without FCF holding above $550M, or if revenue turns negative on the next two prints—evidence that the customer base is truly shrinking rather than just squeezing. Conversely, stabilization of operating income near $630–650M with continued mid-single-digit revenue growth would confirm the market’s secular-decline discount is overdone.
Qwen Reading local experiment · off-panel
The number that decides this case is the operating-margin trajectory: $664.8M in 2022, $654.0M in 2023, $628.6M in 2024 on revenue that grew from $4.58B to $5.00B over the same span. Revenue is compounding at roughly 4.6% per year, but operating margin has slipped from 14.5% to 12.6% in two years, and net income has drifted from $549.5M to $493.2M. That is a "revenue up, margin down" story, not a broken business, but it is not the clean compounding machine the bull narrative implies. The 2021 net-income figure of $688.4M is a clear outlier relative to its neighbours and distorts the five-year earnings CAGR of −5.3% reported in the momentum block; stripping it, the three-year NI trend is roughly flat to slightly negative, which is the honest read.
On the EV bridge: market cap $6.47B, plus net debt of $300M ($646.3M debt less $346.1M cash), gives an enterprise value of approximately $6.77B. Against $618.9M of free cash flow, that is 10.9x EV/FCF. Against $5.00B of revenue, it is 1.35x EV/Revenue. Against the $493.2M of 2024 net income, the P/E is roughly 13.1x (the stated 14.4x likely reflects a slightly different share count or timing). For a software-infrastructure hybrid with a meaningful services component, 13x earnings and 11x FCF sit in the middle of the 8–15x range that characterises the peer group; they are not the 25–30x multiples of pure SaaS, and they are not the 6–8x of a pure IT-services shop. The 3.64% dividend yield at a 43% payout ratio is a real cash return that anchors the downside. ROIC of 13.9% clears a reasonable cost of equity, and the balance sheet carries only $300M of net debt against $3.50B of equity — no solvency question.
The prior models split into two camps that the data does not fully support. The Valuation Synthesis lands at $88.48, implying roughly 18x trailing earnings or 14x FCF — a multiple that would be appropriate for a 10%+ grower with expanding margins, not a 4–5% grower with compressing ones. The Market Forces "value trap" label, by contrast, overstates the damage: revenue is still growing, FCF is $619M (a 12.4% margin), and there is no evidence of customer loss or revenue cliff in the annual data. The truth is that the market is pricing in the margin compression it has already seen, and the 13x multiple reflects a business that is generating solid cash but not re-accelerating. The insider data confirms neutrality: one 464-share sale (noise) and one 84,483-share A-Award (a grant, not a purchase). No conviction signal in either direction.
The strongest case against a "fairly valued" call is the two-year operating-margin slide. If the 12.6% operating margin continues to erode toward 10–11% — plausible if the services mix grows faster than the software mix, or if telecom operators squeeze pricing in a capex-constrained environment — net income could fall to $400–440M. At a 12x multiple that implies a $4.8–5.3B market cap, or roughly $46–51 per share, a 17–25% drawdown from here. A smart bear would also point to the "Lagging Sector Peers" tag and the 2.4% recent revenue YoY, arguing that the 4.6% CAGR is decelerating. I weigh this risk seriously, but the FCF floor of $619M and the 3.6% dividend make a sub-$50 outcome a tail scenario rather than the base case, because it would require both margin compression and a multiple contraction to 10x simultaneously.
What would change my mind in either direction: a quarterly print showing operating margin stabilising or expanding (even a 50-basis-point recovery would validate the 14–15x multiple and push fair value toward $75), or conversely a second consecutive quarter of margin decline below 12% combined with a revenue deceleration below 2%, which would confirm the value-trap thesis and make $50 the more likely equilibrium. The SaaS-versus-services revenue split, which the briefing does not break out, is the single most important missing data point for judging whether the margin trend is structural or cyclical.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Amdocs is a classic mature_earner: revenue has compounded modestly from $4.17B (2020) to $5.00B (2024), roughly 4.6% CAGR, with gross margin stable in a tight 33.9-35.4% band. Cash generation is genuine and high-quality - FCF of $618.9M on $493.2M net income (OCF/NI 1.41x), accruals -3.5% of assets, Beneish -2.56 and Altman Z 4.01 all indicate clean, non-manipulated earnings. Capital returns are shareholder-friendly: diluted share count fell from 133.2M to 116.0M (-3.4% CAGR), and buybacks run 7.2x SBC, so per-share value is being concentrated rather than diluted. SBC at 2.1% of revenue is restrained for software/IT services. The concern that keeps this out of the Strong bracket is the operating margin drift: OpM% went 14.3 -> 14.0 -> 14.5 -> 13.4 -> 12.6, and net income has actually declined from a 2021 peak of $688.4M to $493.2M in 2024 despite revenue up ~17% over the same window. That is negative operating leverage in a mature business - costs are growing faster than the top line. Balance sheet is adequate but not a cushion: $346M cash against net debt of -$300M, so liquidity depends on the FCF engine continuing to fire. Insider tape is a non-event (one tiny $29K sale, one award).
Verify before trusting this (5)
- Cause of the 2022-2024 OpM% decline - is it mix shift (managed services vs software), wage inflation, or specific contract writedowns?
- Customer concentration in top telecom carriers (AT&T, T-Mobile historically large) - any renewal or scope-reduction risk in the 10-K?
- Composition of the net debt position - maturity schedule and covenants on outstanding borrowings.
- Backlog / 12-month bookings trend versus reported revenue growth to gauge forward organic momentum.
- Whether declining net income reflects one-time charges (restructuring, tax) or genuine operating decay.
The e2e composite fair value of $91.87 (signal-adjusted $88.48) implies ~44% upside, but that composite leans on a DCF at $102.98 and an anchored P/E at $99.01 that assume the operating-margin slippage reverses. The EPV floor of $62.49 sits essentially on top of today's $61.35 price, meaning the market is paying roughly for the current earnings stream with no growth credit. That is a meaningful tell: even a no-growth, quality-adjusted valuation supports today's price. Quality is solid (grade 39, high earnings quality), so I don't need to haircut cash earnings much - what you see is what you get. Splitting the difference between the EPV floor and the growth-based methods, and docking for the ~200bps operating margin erosion the quality lens flagged, I land on a deserved value in the $72-78 range. Against $61.35 that is a ~15-25% gap - real, but not a fat-pitch discount. This is a mature compounder the market has partially written off on telecom-secular fears, not a screaming dislocation.
Verify before trusting this (4)
- Operating margin trajectory in latest quarter - is the 200bps slide stabilizing or continuing
- Managed-services vs SaaS revenue mix and growth rates
- Buyback pace and remaining authorization
- Top-customer concentration and any renewal terms with AT&T, T-Mobile
DOX is the textbook low-pressure name: beta 0.42, a steady-compounder archetype with minimal narrative intensity and low cult coefficient. The risk-on tape (VIX 15, S&P near highs) is a mild tailwind for equities broadly, but at 0.42 beta the market barely tugs this name. There is no active narrative running hot in either direction - the bull case (telecom back-office moat, managed services record) and bear case (legacy IT vendor to squeezed telcos, AI disruption) are both dormant rather than trending. That is itself a mild positive: nothing is de-rating this stock. The Q3 print in early August matched estimates with record managed services and reaffirmed guidance - a non-event that quietly supports the compounder narrative rather than igniting it. The 3.93% pop on Aug 19 with no headlines suggests some buyer showed up on technicals or a sector bid, not a story change. Analyst tone is not flagged as diverging. Net: this is a name where sentiment is close to neutral with a whisper of tailwind from the calm tape and the recent uneventful print, offset by a background bear framing (AI threat to services-heavy models) that could re-emerge if the AI-disruption narrative broadens to enterprise IT services.
Verify before trusting this (4)
- Whether analyst target revisions post-Q3 skew positive or negative - would tilt the balance
- Any broadening of the 'AI eats IT services' narrative (Accenture, Cognizant, Infosys tape) that would drag DOX by association
- Telecom operator capex commentary from major carriers (AT&T, Verizon, T-Mobile) that would pressure or lift the demand narrative
- Whether the Aug 19 move extends into a real trend or fades - a tell on quiet institutional positioning
The world Amdocs sells into is not expanding, but it is being forced to re-platform. Carriers have flat-to-declining revenue, constrained capex, and a macro backdrop of higher-for-longer rates (10y 4.69) that argues for opex discipline over greenfield spend. That cuts both ways: it caps deal size but strengthens the case for outsourcing operations to a vendor who can run the stack cheaper. The genuine structural question is whether generative AI compresses the effort a carrier needs to buy. Amdocs' answer — sell the AI layer itself and shift toward product/managed outcomes — is credible but unproven at scale; the negative multi-year earnings CAGR against positive revenue CAGR suggests the pricing transition is already costing something. Net: a durable, mission-critical annuity attached to a stagnant customer base, with the direction of change roughly neutral rather than either broken or inflecting.
When we made this prediction on Aug 23, 2026, DOX was $61.35. We expect it to be $73.50 by Feb 2027, and we consider it great value under $55.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 23, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.
Post-Report Due Diligence NOTES
Evidence for a closer look, not a verdict — no score or designation on this page has been changed by it. Items marked material are ones where a conclusion above moves to the other side of the price.
adjusted_earnings
flips up 10%
cost_of_capital
flips down 10%
shares
flips down 10%